CD4 and B-cell chronic lymphocytic leukemia: In an independent series of 49 CLL patients, upregulation of mo-MDSCs significantly inhibited the CD4+ T-cell immune response and were correlated with the presence of CD4+ T- and CD5+CD19+ cells, contributing to disease progression and a poor prognosis.